Cargando…
S296: IL-1Β SIGNALLING INDUCES, AND BARICITINIB ALLEVIATES NEU1-MEDIATED MEGAKARYOCYTE DESIALYLATION IN IMMUNE THROMBOCYTOPENIA
Autores principales: | Zhao, Peng, An, Zhuo-Yu, Fu, Hai-Xia, Liu, Hui-Xin, Yang, LI-Ping, Qu, Qing-Yuan, Huang, Qiu-Sha, Wu, Jin, Wu, Ye-Jun, Chen, Yu-Xiu, LI, Meng-Lin, Wang, Chencong, Zhu, Xiaolu, He, Yun, LI, Juan-Juan, Zhang, Yuan-Yuan, Jiang, Qian, Jiang, Hao, Lu, Jin, Chang, Ying-Jun, Zhao, Xiao-Su, Zhao, Xiang-Yu, Huang, Xiao-Jun, Zhang, Xiao-Hui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428299/ http://dx.doi.org/10.1097/01.HS9.0000968096.73161.e9 |
Ejemplares similares
-
P1594: BARICITINIB FOR STEROID-RESISTANT/RELAPSE IMMUNE THROMBOCYTOPENIA (BAITP): AN OPEN-LABEL, SINGLE-ARM, PHASE 2 TRIAL
por: Zhao, Peng, et al.
Publicado: (2023) -
Desialylation is associated with apoptosis and phagocytosis of platelets in patients with prolonged isolated thrombocytopenia after allo-HSCT
por: Zhang, Xiao-Hui, et al.
Publicado: (2015) -
Platelet desialylation is a novel mechanism and a therapeutic target in thrombocytopenia during sepsis: an open-label, multicenter, randomized controlled trial
por: Li, Mei-feng, et al.
Publicado: (2017) -
MicroRNA-223 reversibly regulates erythroid and megakaryocytic differentiation of K562 cells
por: Yuan, Jin-Yun, et al.
Publicado: (2009) -
Platelet desialylation correlates with efficacy of first-line therapies for immune thrombocytopenia
por: Tao, Lili, et al.
Publicado: (2017)